Ralfinamide
Top View
- Customs Tariff - Schedule Xxi - 1
- Farmacoterapia Para El Control Del Dolor: Pautas De Uso (2008)
- Synthetic Approaches to the New Drugs Approved During 2015 † ‡ † § ∥ Andrew C
- Study of Genetic Factors Involved in Pain Perception and Morphine Analgesia in Cancer-Related Pain
- Co-Crystals of Duloxetine and Co-Crystal Formers for the Treatment
- Allergen Extracts Prior Authorization Guidelines
- 207145Orig1s000
- Newron Completes Enrolment in SERENA Phase Iib/III Study of Ralfinamide in Patients with Neuropathic Low Back Pain
- (12) Patent Application Publication (10) Pub. No.: US 2014/0243254 A1 Hersel Et Al
- Membrane Transporter/Ion Channel Compound Library (96-Well)
- Us8076515b2-8-10-2021 Aug 10, 2021
- (12) Patent Application Publication (10) Pub. No.: US 2014/0296257 A1 Hersel Et Al
- Supplemental Materials
- A Pharmacological Interactome Between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic
- Drug Repurposing Compound Library (96-Well)
- Newron Pharmaceuticals S.P.A. ("Newron") Solely for Your Information
- N Ew Ron Reports Positive Phase II Results for Ralfinam Ide in Peripheral Neuropathic Pain Patients
- EP Vantage Interview - Newron Eyeing US Acquisition